RXST Q1 2024 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena

RXSTRxSight, Inc.

$313M

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$30M+68.7% YoY

Gross Profit

$21M70.1% margin

Operating Income

-$11M-36.2% margin

Net Income

-$9M-30.8% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+3.3%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$11M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$183M

Total Liabilities

$19M

Stockholders' Equity

$164M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$17M	+68.7%
Gross Profit	$21M	$10M	+99.5%
Operating Income	-$11M	-$13M	+18.5%
Net Income	-$9M	-$13M	+31.1%

Revenue Segments

L D D

$9M91%

Service Warranty Service Contracts And Accessories

$882,0009%